HTMwire assessment
MedSecure USA is a consultancy specializing in FDA Section 524B premarket cybersecurity documentation for medical device manufacturers. It produces a fixed-price package of the 12 documents a cyber device submission requires, including the Security Risk Management Plan, threat model and security architecture, machine-readable SBOM and vulnerability assessment, penetration test report, labeling, and vulnerability disclosure policies, with a stated 6 to 8 week delivery. The buyer is the device manufacturer preparing an FDA submission, so for hospital HTM teams this is manufacturer-facing context rather than a direct purchase.
A fixed-price, productized FDA Section 524B premarket package delivering all 12 required cybersecurity documents in a stated 6 to 8 week window.
HTMwire's independent read on the technology — not the vendor's marketing claim.
It is for medical device manufacturers and device sponsors. FDA Section 524B applies to premarket submissions by manufacturers, not hospitals, so MedSecure USA's package is manufacturer-facing and only contextually relevant to hospital HTM teams.
A fixed-price set of all 12 documents a cyber device submission requires, including the Security Risk Management Plan, threat model and security architecture, machine-readable SBOM and vulnerability assessment, SOUP/OTS assessment, penetration test report, labeling additions, vulnerability disclosure and coordinated disclosure policies, and a post-market monitoring plan.
MedSecure USA advertises fixed pricing scoped upfront and a stated delivery window of 6 to 8 weeks for the full premarket cybersecurity package.
The company states it is current on the February 2026 FDA Final Guidance (GUI00001825) and the QMSR, and describes itself as a specialist in FDA Section 524B.
We cite a primary or named source for every claim on this page. How we evaluate →